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In the United States (USA), a correlation has been demonstrated between socio-economic status (SES) of patients on the one hand,
and tumour histology, stage of the disease and treatment modality of various cancer types on the other hand. It is unknown whether
such correlations are also involved in patients with oesophageal cancer in The Netherlands. Between 1994 and 2003, 888
oesophageal cancer patients were included in a prospective database with findings on the diagnostic work-up and treatment of
oesophageal cancer. Socio-economic status of patients was defined as the average net yearly income. Linear-by-linear association
testing revealed that oesophageal adenocarcinoma was more frequently observed in patients with higher SES and squamous cell
carcinoma in patients with lower SES (P¼0.02). Multivariable logistic regression analysis showed no correlation between SES and
staging procedures and preoperative TNM stage. The adjusted odds ratio (OR) for stent placement was 0.82 (95% CI 0.71–0.95),
indicating that with an increase in SES by 1200h, the likelihood that a stent was placed declined by 18%. Patients with a higher SES
more frequently underwent resection or were treated with chemotherapy (OR: 1.15; 95% CI 1.01–1.32 and OR: 1.16; 95% CI 1.02–
1.32, respectively). Socio-economic factors are involved in oesophageal cancer in The Netherlands, as patients with a higher SES are
more likely to have an adenocarcinoma and patients with a lower SES a squamous cell carcinoma. Moreover, the correlations
between SES and different treatment modalities suggest that both patient and doctor determinants contribute to the decision on the
most optimal treatment modality in patients with oesophageal cancer.
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Oesophageal carcinoma is currently on the sixth place of estimated
cancer deaths worldwide (Parkin et al, 2001). Patients with
oesophageal cancer have a dismal prognosis, as more than 50%
of patients have already locally advanced carcinoma, lymph node
metastases, or distant metastases at the time of presentation
(Lightdale, 1999).
In the United States (USA), a correlation between socio-
economic status (SES) of patients and the histology of oesophageal
cancer has been demonstrated. Patients with a higher SES had a
higher incidence of oesophageal adenocarcinoma, whereas squa-
mous cell carcinoma was more frequently found in patients with a
lower SES (Brown et al, 2001).
It has also been reported that patients with a lower SES were less
likely to have localised cancer at diagnosis, compared with patients
with a higher SES in the USA. This correlation was found for
various cancers, that is, carcinomas of the breast (Li et al, 2003;
Ward et al, 2004), uterine cervix (Ward et al, 2004) and
oesophagus (Silverstein et al, 2002).
Finally, for breast cancer (Li et al, 2003; Ward et al, 2004)
differences in the use of specific treatment modalities were present
for SES in the USA. Patients with a higher SES were more likely to
undergo a more appropriate treatment modality compared to
patients with a lower SES, meaning that patients with a lower SES
were at risk to receive unsatisfactory health care.
It is unknown whether in European countries a correlation is
present between SES of patients with oesophageal cancer on the
one hand, and tumour histology, staging approach, preoperative
TNM stage and treatment modality on the other hand. In the
present study we investigate these correlations in The Netherlands.
PATIENTS AND METHODS
Patients and database
In the Erasmus MC Rotterdam, The Netherlands, a prospective
database is 2-weekly updated with information on patients who
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shave been diagnosed with and treated for oesophageal or gastric
cardia cancer from January 1994 until now. The database contains
information on general characteristics, preoperative investigations
and treatment modalities employed in these patients. In this study,
we analysed findings from patients collected in the database
between January 1994 and October 2003. In total, 1088 patients
with oesophageal or gastric cardia cancer were seen in this period.
Socio-economic status could be determined in 1078 patients. Of
these, 888 patients had squamous cell carcinoma or adenocarci-
noma of the oesophagus. In the remaining 190 patients, gastric
cardia carcinoma (n¼107) or oesophageal cancer with another
histology (n¼83) was found and these patients were excluded
from the analysis. Information, not present in the database, but
necessary for this study, was obtained from the electronic ‘hospital
information system’, which contains additional clinical informa-
tion on these patients. From the electronic ‘hospital information
system’, we retrospectively collected information on whether a
cancer located at the gastrooesophageal junction was in fact an
oesophageal or a gastric cardia cancer. Other information retro-
spectively obtained from the electronic ‘hospital information
system’ included information on chest X-rays (performed or not,
and if yes the result), bronchoscopies (performed or not, and if yes
the result) and CT scan results. Furthermore, the preoperative
TNM stage was retrospectively determined using the results of the
preoperative investigations performed.
Socio-economic status
We defined SES of patients as the average net yearly income of
income receivers with 52 weeks of income. The Central Office of
Statistics in The Netherlands (CBS, The Netherlands) collects
information on net yearly income, which is collected on a zip code
level. Each zip code area represents approximately 4000 inhabi-
tants. The database contains zip codes of patients and SES of
patients was determined by means of these zip codes. Information
on net yearly income was used from 1999. The use of information
on SES with zip codes has been reported in other studies as well
(Franks and Fiscella, 2002; Franks et al, 2003; Yoo and Thuluvath,
2004; Stern et al, 2005).
The SES varied between h11800 and h22100. For this study, we
divided SES into three equal parts, that is, group 1: oh14600
(N¼295), group 2: h14600–h15800 (N¼291) and group 3:
4h15800 (N¼302). In The Netherlands, the mean net yearly
income was 15900h in 2000 (Central office of statistics (CBS),
January 2006).
Tumour histology
Tumour histology was determined by means of investigation of
biopsy specimens from the oesophageal tumour, which were
obtained by endoscopy and examined by an experienced gastro-
intestinal pathologist. Patients were subdivided into those with
oesophageal squamous cell carcinoma or adenocarcinoma. Oeso-
phageal adenocarcinoma was present if the carcinoma was found
in Barrett’s oesophagus, or, in the absence of Barrett’s oesophagus,
if more than 50% of the adenocarcinoma was found in the
oesophagus.
Staging approach
Preoperative investigations, which are commonly performed in
patients with oesophageal carcinoma, include chest X-ray (Stein
et al, 2001), endoscopic ultrasonography (EUS) (Vickers and
Alderson, 1998), CT scan (Maerz et al, 1993), ultrasound (US) of
neck (Griffith et al, 2000) and abdomen (van Overhagen et al,
1992) and bronchoscopy (Riedel et al, 1998) in case of a carcinoma
at or above the level of the carina. Patients who were included in
this study were predominantly diagnosed in regional centers. After
diagnosis, presumably curable patients are referred to our centre
where they undergo (repeat) preoperative staging investigations.
For all patients included in this study, only preoperative
investigations performed in our centre were taken into considera-
tion.
Preoperative TNM stage
The preoperative TNM stage was determined as a result of the
preoperative staging investigations. The T stage describes the
depth of infiltration of the cancer into the different layers of the
oesophageal wall. T stage was subdivided into T1 to T4, with a T1-
carcinoma representing infiltration into the mucosa (T1m) or
submucosa (T1sm), a T2 infiltrating into the muscularis propria, a
T3 extending through the muscularis propria and a T4 infiltrating
into surrounding organs or vessels. The N stage indicates the
absence (N0) or presence (N1) of regional lymph node metastases
and the M stage describes the absence (M0) or presence (M1) of
distant metastases, with M1 stage being subdivided into an M1a-
and M1b-stage (Fleming et al, 1997). When an item of the TNM-
staging system was not available, this was staged as unknown. For
example, if T stage was unknown, T stage was considered as Tx.
Treatment modality
Treatment modalities, which were performed in the patients with
oesophageal carcinoma, were an oesophageal resection, stent
placement, chemotherapy, radiation therapy, a combination of
chemotherapy and resection, or a combination of chemotherapy,
radiation therapy and resection. For each patient, it was
determined whether oesophageal resection, chemotherapy, radia-
tion therapy or stent placement had been performed.
Statistical analyses
Linear-by-linear association testing (w
2 testing) was used to
determine a correlation between SES and tumour histology, extent
of preoperative investigations, TNM stage and treatment modality.
For preoperative investigations, multivariable logistic regression
was performed to correct for confounders. The included covariates
were age, gender, tumour histology, comorbidity, tumour location
and SES divided by 1200. The SES was divided by 1200 as the
possible effect per euro was expected to be small. The number 1200
includes the difference between the lowest and highest income of
group 2 (h 14600–h15800). The number 1200 is, however, not a
universal number used in multivariable logistic regression
analysis. If the difference between the lowest and highest income
of group 2 had been, for example, 1400, we would have divided SES
by 1400. Comorbidity comprised all other disorders of patients
that required medical treatment, such as cardiac or lung diseases.
Tumour location was divided into five groups, that is, cervical,
upper 1/3, middle 1/3 and lower 1/3 thoracic oesophagus and
gastrooesophageal junction.
For N and M stages, we also performed multivariable logistic
regression. M stage was subdivided into M0 and M1 stage, with M1
stage containing both M1a and M1b stages. The included
covariates were age, gender, tumour histology, comorbidity,
tumour location, tumour stage, preoperative investigations and
SES divided by 1200. Multivariable logistic regression was not
performed for T stage, as T stage was subdivided into four groups,
that is, T1–T4, and for multivariable logistic regression the
dependent variable should be dichotomous.
To correct for confounders in the possible correlation between
SES and treatment modality, multivariable logistic regression was
performed. We included the covariates age, gender, tumour
histology, comorbidity, tumour location, tumour stage (TNM
stage), preoperative investigations and SES divided by 1200.
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sSoftware used for analysis was SPSS (SPSS, Chicago, IL, USA).
All P-values were based on two-sided tests of significance. A P-
value o0.05 was considered as statistically significant.
RESULTS
Patient and tumour characteristics
Patient and tumour characteristics of the 888 patients with
oesophageal carcinoma who were included in this study are shown
in Table 1.
Tumour histology
Table 2 shows the number of patients with squamous cell
carcinoma or adenocarcinoma per income group. We found a
lower percentage of oesophageal squamous cell carcinoma patients
with increasing income. In contrast, the percentage of adenocarci-
noma cases increased with higher SES (P¼0.02).
Staging approach
The numbers of patients who underwent EUS, CT scan, US neck,
US abdomen, chest X-ray or bronchoscopy per income group are
shown in Table 3. The linear-by-linear association test was only
statistically significant for bronchoscopy (P¼0.04), demonstrating
that patients with a lower SES underwent more often a
bronchoscopy. P-values for EUS (P¼0.92), CT scan (P¼0.14),
US neck (P¼0.44), US abdomen (P¼0.34) and chest X-ray
(P¼0.48) were not statistically significant.
Table 4 shows the results of the multivariable logistic regression
analyses. This table shows that the adjusted odds ratios (ORs) of
the preoperative investigations were not statistically significant.
The reason that bronchoscopy was not statistically significant in
multivariable logistic regression analyses, while it was statistically
significant in the linear-by-linear association test, was that
bronchoscopy was more often performed in patients with
squamous cell carcinoma compared to patients with adenocarci-
noma (data not shown).
Preoperative TNM stage
T, N and M stages per income group are shown in Table 5. T stage
was unknown in 284 patients, and in these patients T stage was
considered as Tx (Table 5). The linear-by-linear association test
was not significant for T (P¼0.97), N (P¼0.68) and M stage
(P¼0.46).
In Table 6, the results of the multivariable logistic regression
analyses are shown. It was found that the adjusted ORs of N (OR:
0.91; 95% CI 0.81–1.03) and M stage (OR: 0.93; 95% CI 0.81–1.07)
were not statistically significant.
Table 1 Patient and tumour characteristics of patients with oesophageal
carcinoma (n¼888)
Characteristics
Mean age7s.d. (years) 62.7710.1
Gender (%)
Male 678 (76)
Female 210 (24)
Histology of tumour (%)
Squamous cell carcinoma 388 (44)
Adenocarcinoma 500 (56)
Location of tumour (%)
Cervical 10 (1)
Upper 1/3 thoracic 43 (5)
Middle 1/3 thoracic 158 (18)
Lower 1/3 thoracic 406 (46)
Gastrooesophageal junction 271 (30)
Table 2 Number of patients with oesophageal SCC or AC per income
group
Socio-economic status in Euro
Histology
o14600
(N¼295)
14600–15800
(N¼291)
415800
(N¼302)
SCC (%) 147 (50) 119 (41) 122 (40)
AC (%) 148 (50) 172 (59) 180 (60)
Linear-by-linear association test: P¼0.021. AC, adenocarcinoma; SCC, squamous cell
carcinoma.
Table 3 Numbers of patients with EUS, CT scan, ultrasound neck, ultrasound abdomen, chest X-ray or bronchoscopy per income group
Socio-economic status in Euro
Investigation o14600 (N¼295) 14600–15800 (N¼291) 415800 (N¼302) P-value
a
EUS (%) 199 (68) 203 (70) 205 (68) 0.915
CT scan (%) 175 (59) 169 (58) 161 (53) 0.138
Ultrasound neck (%) 263 (89) 253 (87) 263 (87) 0.444
Ultrasound abdomen (%) 188 (64) 178 (61) 181 (60) 0.341
Chest X-ray (%) 211 (72) 202 (69) 208 (69) 0.481
Bronchoscopy (%) 84 (29) 59 (20) 64 (21) 0.036
aLinear-by-linear association test. CT, computed tomography; EUS, endoscopic ultrasonography.
Table 4 Multivariable logistic regression to determine whether a
correlation existed between SES and preoperative investigations in patients
with oesophageal carcinoma
Investigation OR 95% confidence interval P-value
EUS 0.997 0.887–1.120 0.955
CT scan 0.960 0.861–1.071 0.466
Ultrasound neck 0.997 0.845–1.175 0.968
Ultrasound abdomen 0.957 0.858–1.068 0.434
Chest X-ray 0.968 0.862–1.088 0.590
Bronchoscopy 0.951 0.828–1.092 0.473
Covariates: age, gender, tumour histology, comorbidity, tumour location and SES/
1200. CT, computed tomography; EUS, endoscopic ultrasonography; OR, odds ratio;
SES, socio-economic status.
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The numbers of patients who underwent resection, stent place-
ment, chemotherapy or radiation therapy per income group are
shown in Table 7. In 40 patients, no treatment was given. In the
remaining 848 patients, more than one treatment modality has
been employed in a subgroup of patients. The linear-by-linear
association test was statistically significant for resection
(P¼0.001), showing that more resections were performed in
patients with a higher SES. For stent placement, the linear-by-
linear association test was also statistically significant (P¼0.001).
The negative correlation between SES and stent placement shows
that fewer stent placements were performed in patients with a
higher SES.
The results of the multivariable logistic regression analyses are
shown in Table 8. It was found that the adjusted OR for stent
placement was still statistically significant with a value of 0.82
(95% CI 0.71–0.95), meaning that with an increase in SES by
1200h, the likelihood that a stent was placed declined by 18%.
Furthermore, the adjusted ORs for resection and chemotherapy
were also just statistically significant (OR: 1.15; 95% CI 1.01–1.31
and OR: 1.16; 95% CI 1.02–1.32, respectively), showing that
resection and chemotherapy were more often performed with
increasing SES. No correlation was found between SES and
radiation therapy (OR: 1.04; 95% CI 0.90–1.22).
DISCUSSION
In this study, a statistically significant correlation was demon-
strated between SES, defined as average net yearly income of
income receivers with 52 weeks of income, and histology of an
oesophageal carcinoma. The incidence of squamous cell carcinoma
declined and the incidence of adenocarcinoma increased with
increasing SES. Our analyses demonstrated no correlation between
SES and extent of staging procedures and between SES and
preoperative TNM stage. A statistically significant negative
correlation was however present between SES and stent placement,
whereas a statistically significant positive correlation was present
between SES and undergoing resection and between SES and
undergoing chemotherapy. No correlation was found between SES
and undergoing radiation therapy.
Well-known risk factors for oesophageal squamous cell carcino-
ma include smoking and alcohol consumption (Brown et al, 2001;
Engel et al, 2003; Crew and Neugut, 2004). Gastrooesophageal reflux
disease and obesity are identified risk factors for oesophageal
adenocarcinoma (Engel et al, 2003; Crew and Neugut, 2004). In the
USA, adenocarcinoma is more often found in patients with a higher
SES, whereas squamous cell carcinoma is more common among
patients with a lower SES (Brown et al,2 0 0 1 ) .T h i sp r e v i o u s l y
observed correlation between SES and tumour histology was also
found in the present study performed in The Netherlands. Although
we had no information on risk factors in the patients with
oesophageal cancer in this study, our results suggest that the higher
prevalence of squamous cell cancer in the lower SES patients is due
to more common smoking habits and alcohol consumption in these
patients, whereas in patients with a higher income risk factors for
GERD are more prominent. This is line with findings on smoking
and alcohol consumption in the literature (Schnohr et al, 2004;
Honjo et al,2 0 0 6 ) .
In The Netherlands, general practitioners are the gatekeepers of
the health care system, meaning that patients usually first consult
the general practitioner for symptoms before being referred to a
hospital (Kulu-Glasgow et al, 1998). In general, it is true that there
is a low threshold and there are no economical barriers for patients
to consult a general practitioner. In the present study, no
statistically significant correlation was found between SES and
performing preoperative staging investigations and between SES
and TNM stage. This is likely to be explained by the fact that health
insurance covers almost all people in The Netherlands, resulting in
a similar access to health care faculties for all income groups.
Table 5 T, N and M stages per income group
Socio-economic status in Euro
Stage
o14600
(N¼295)
14600–15800
(N¼291)
415800
(N¼302) P-value*
T stage 0.972
T1 (%) 7 (2) 7 (2) 6 (2)
T2 (%) 28 (10) 31 (11) 25 (8)
T3 (%) 136 (46) 144 (49) 151 (50)
T4 (%) 29 (10) 19 (7) 21 (7)
Tx (%) 95 (32) 90 (31) 99 (33)
N stage 0.680
N0 (%) 166 (56) 167 (57) 175 (58)
N1 (%) 129 (44) 124 (43) 127 (42)
M stage 0.459
M0 (%) 225 (76) 235 (81) 238 (79)
M1a (%) 29 (10) 26 (9) 27 (9)
M1b (%) 41 (14) 30 (10) 37 (12)
*Linear-by-linear association test.
Table 6 Multivariable logistic regression to determine whether a
correlation existed between SES and preoperative N and M stages in
patients with oesophageal carcinoma
Stage OR 95% confidence interval P-value
N 0.913 0.811–1.029 0.137
M 0.932 0.813–1.068 0.310
Covariates: age, gender, tumour histology, comorbidity, tumour location, tumour
stage, preoperative investigations and SES/1200. OR, odds ratio; SES, socio-economic
status.
Table 8 Multivariable logistic regression to determine whether a
correlation existed between SES and treatment modality in patients with
oesophageal carcinoma
Treatment OR 95% confidence interval P-value
Resection (%) 1.152 1.008–1.317 0.038
Stent placement (%) 0.822 0.712–0.949 0.008
Chemotherapy (%) 1.155 1.015–1.315 0.029
Radiation therapy (%) 1.043 0.895–1.215 0.592
Covariates: age, gender, tumour histology, comorbidity, tumour location, tumour
stage, preoperative investigations and SES/1200. OR, odds ratio; SES, socio-economic
status.
Table 7 Numbers of patients with oesophageal resection, stent
placement, chemotherapy or radiation therapy
Socio-economic status in Euro
Treatment
o14600
(N¼289)
14600–15800
(N¼280)
415800
(N¼291)
P-
value*
Resection (%) 154 (52) 176 (61) 197 (65) 0.001
Stent placement (%) 86 (29) 61 (21) 55 (18) 0.001
Chemotherapy (%) 117 (40) 123 (42) 132 (44) 0.317
Radiation therapy (%) 43 (15) 56 (19) 47 (16) 0.753
*Linear-by-linear association test.
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oesophageal cancer have been reported for race. Non-Caucasian
patients had a higher risk of receiving a less than optimal
treatment compared with Caucasian patients, that is, non-
Caucasian patients were less likely to receive an oesophagectomy
and more likely to receive chemotherapy and/or radiation therapy
(Dominitz et al, 2002). Factors that have been previously reported
to be important in the differences in treatment modalities for both
race and SES in the USA included differences in attitudes toward
invasive procedures, disease severity, access to care (Dominitz
et al, 2002), differences in undergoing staging procedures (Merrill
et al, 2000), and issues related to health insurance (Mandelblatt
et al, 1999).
The treatment preferences and attitudes toward invasive
procedures of patients in the USA could be important explanations
for the differences in use of treatment modalities in the USA. It is
possible that treatment preferences and attitudes toward invasive
procedures were also factors of importance in The Netherlands. In
the present study, stent placement was more often performed in
patients with a lower SES and oesophageal resection and the
administration of chemotherapy were more common in patients
with a higher SES. This might well suggest that patients in a higher
income class are more eager to explore all therapeutic options,
even experimental, to overcome the malignant disease they are
suffering from. This is however speculative and we have no firm
evidence to confirm this option. Furthermore, doctor contribu-
tions might also be important in the decision making on the most
optimal treatment modality in patients, as it can be suspected that
doctors are more willing to discuss all treatment options with
patients if they are in the same income class, which often
represents the same educational level.
In the USA, patients with a higher SES were more likely to have a
localised cancer stage at diagnosis, compared with patients with a
lower SES (Silverstein et al, 2002). Patient with locally advanced
carcinoma or distant metastases will not receive an oesophageal
resection and more often undergo treatment with chemotherapy
and/or radiation therapy, which likely explains the differences in
treatment modalities between different income classes in the USA.
In the present study, no differences in preoperative TNM stage
were found and as a consequence, disease stage is probably not
important in the correlation between SES and treatment modality
in The Netherlands.
In the USA, non-Caucasian patients were more often under-
staged, that is, underwent fewer preoperative staging investiga-
tions, in comparison with Caucasian patients (Merrill et al, 2000).
In the present study, no correlation was found between SES and
performing preoperative investigations and, as a consequence, this
factor could not be an explanation for the correlations found
between SES and treatment modality.
It has been reported that the health insurance status of a patient
has an effect on the use of treatment modalities. For non-small-cell
lung carcinoma, it has been shown that patients with private
insurance were more likely to undergo a lung resection compared
with patients without private insurance (Greenberg et al, 1988). In
The Netherlands, almost all (499%) inhabitants have a health
insurance, resulting in similar health care services for all income
groups. For that reason, differences in health insurance cannot
explain the correlation between SES and treatment modality in The
Netherlands.
What are other possible explanations for the observed
differences on the role that SES plays in the diagnosis and
treatment of oesophageal carcinoma patients between the USA and
The Netherlands? First, almost all patients in this study were
Caucasian. In the USA, the patients had different ethnic back-
grounds and it has been demonstrated that differences in
performing preoperative staging investigations, TNM stage and
use of treatment modalities were not only present for SES but also
for race (Klabunde et al, 1998; Bach et al, 1999; Merrill et al, 2000;
Dominitz et al, 2002; Tomar et al, 2004; Ward et al, 2004;
Steyerberg et al, 2005). As a consequence, race might be a more
important factor compared to SES.
Second, people who are unemployed usually receive welfare in
The Netherlands. As a consequence, the contrast between low- and
high-income patients is probably smaller in The Netherlands in
comparison with the USA. Therefore, the contrast between poor
and rich was probably too small in this study to demonstrate the
presence of differences in performing preoperative staging
investigations and TNM stage.
Third, differences are present in health insurance and access to
care. The majority of lower SES patients in The Netherlands have
health insurance, which they receive from the Dutch National
Health Service, whereas patients with higher SES pay health
insurance themselves. As a consequence, almost all people in The
Netherlands have health insurance, which means that access to
care is equal, and similar health care services are available for all
income groups. In the USA, not all patients have similar health
care insurance and service, which could be responsible for the
differences between the USA and The Netherlands.
There are several limitations to this study. First, in the present
database with oesophageal cancer patients, no direct measures of
SES were available. Nevertheless, the zip code of nearly all patients
was present in the database. The Central Office of Statistics (CBS,
The Netherlands) has designed a measure of SES by zip code
representing the median net yearly income of an average of 4000
inhabitants. This information was used to determine the SES of
individual patients. A disadvantage of this method is that an
aggregate measure of SES was used for the SES of each individual
patient. Another disadvantage could be that SES was relatively
roughly determined, as it was estimated on the SES of an average
of 4000 inhabitants, because there was no measure at the
individual level available. Nevertheless, it has been demonstrated
that health differences could be slightly more prominent when a
more accurate measure of SES is used (Smits et al, 2005),
suggesting that the differences could be underestimated in this
study. In our opinion, it is unlikely that using a more accurate
measure of SES would have changed the pattern of correlations.
Second, in the zip code area, the population is heterogeneous for
economic characteristics, that is, not all persons in that particular
zip code area will have the same SES. In the present study, the
assumption was made that SES was homogeneous within the zip
code area. As a consequence, all persons in one zip code area had
an equal SES. Nevertheless, it could be possible that the SES of a
patient was higher or lower than the average SES of the
corresponding zip code area.
Third, in this study, only 888 patients were included who had
oesophageal squamous cell carcinoma or adenocarcinoma. This is a
relatively low number of patients to determine whether correlations
existed between SES and characteristics of oesophageal cancer.
Fourth, the patients who were included in this study were a
selection of all patients with oesophageal carcinoma in the
southern part of The Netherlands. Usually, oesophageal carcinoma
is diagnosed in regional centers, that is, centers with fewer than 10
patients per year. After diagnosis, patients often undergo
preoperative staging investigations in these centers. Subsequently,
they may be treated in the regional centre or, more often, are
referred to our centre with a volume of more than 100 patients
with oesophageal cancer per year (van Vliet et al, 2006). Patients in
whom distant metastases were present according to the preopera-
tive investigations performed in the regional centers were however
only sporadically referred to our centre, which resulted in a
relatively low number of patients with distant metastases in this
study (Table 5). Furthermore, it is unknown whether other factors,
such as SES or education level, played a role in the referring
pattern of patients to our centre.
In conclusion, a significant correlation was found between SES
of patients with oesophageal cancer and tumour histology. The
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positive correlation between SES and resection and SES and
chemotherapy suggest that patients in a higher income class more
often do an utmost effort to overcome their disease. Furthermore,
doctor contributions may be important in the decision making on
treatment modality.
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